• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Radiosurgery/Radiation therapy

Elekta announces a new CEO

June 9, 2025 By Chris Newmarker

Swedish precision radiation therapy devices and software maker Elekta is bringing in an executive from Denmark to be its new CEO. Elekta today announced the appointment of Jakob Just-Bomholt, who will take over the corner office at the company on Sept. 1, 2025. Just-Bomholt, a Danish citizen, will be based in Stockholm and will start […]

Filed Under: Business/Financial News, Featured, Imaging, Oncology, Radiosurgery/Radiation therapy Tagged With: Elekta, Personnel Moves

Stryker wins FDA clearance for nerve ablation system

May 19, 2025 By Sean Whooley

Stryker announced today that it received FDA 510(k) clearance for its OptaBlate basivertebral nerve ablation system (OptaBlate BVN). Portage, Michigan–based Stryker designed OptaBlate BVN for a targeted minimally invasive procedure. It aims to provide long-lasting vertebrogenic pain relief. Stryker says adding OptaBlate BVN to its pain portfolio expands its advanced pain therapy solutions for patients. […]

Filed Under: 510(k), Featured, Food & Drug Administration (FDA), Orthopedics, Radiosurgery/Radiation therapy, Regulatory/Compliance, Spine Tagged With: FDA, Stryker

NeuroOne completes FDA submission for nerve ablation tech to treat facial pain

April 23, 2025 By Sean Whooley

NeuroOne (Nasdaq:NMTC) announced today that it filed an FDA 510(k) submission for its trigeminal nerve ablation technology. The submission comes in ahead of schedule for the Eden Prairie, Minnesota-based company. Just last month, the company earmarked May for the 510(k) clearance submission. Before that, the company projected a submission by the end of June. Trigeminal […]

Filed Under: Food & Drug Administration (FDA), Neurological, Radiosurgery/Radiation therapy, Regulatory/Compliance Tagged With: FDA, neuroone

NeuroOne says tariffs won’t impact business, Zimmer Biomet deal

April 16, 2025 By Sean Whooley

NeuroOne (Nasdaq:NMTC) CEO Dave Rosa today issued a letter to shareholders outlining the company’s exposure to tariff impact. Tariffs recently announced by the Trump Administration — then paused last week for at least 90 days — have created a stir in the industry. Medtech trade group AdvaMed praised the decision to suspend the tariffs earlier this week, […]

Filed Under: Business/Financial News, Neurological, Pain Management, Radiosurgery/Radiation therapy, Wall Street Beat Tagged With: neuroone, Zimmer Biomet

Innoblative wins FDA IDE for electrosurgical device for breast cancer treatment

April 10, 2025 By Sean Whooley

Innoblative Designs announced today that it received FDA investigational device exemption (IDE) for its Sira RFA electrosurgical device. Chicago-based Innoblative Designs’ SIRA device holds FDA breakthrough device designation. It designed SIRA for use in breast cancer patients undergoing breast-conservation surgery (BCS/lumpectomy). SIRA uses radiofrequency ablation (RFA) through a unique spherical shape that circumferentially delivers RF energy. […]

Filed Under: Featured, Food & Drug Administration (FDA), Oncology, Radiosurgery/Radiation therapy, Regulatory/Compliance, Women's Health Tagged With: FDA, Innoblative, Innoblative Designs

Zeiss wins FDA nod for robotic-assisted radiation tech

April 9, 2025 By Sean Whooley

Zeiss Medical Technology announced today that it received FDA 510(k) clearance for the Intrabeam 700 platform. Intrabeam 700 delivers robotic-assisted precision to support intraoperative radiation therapy (IORT). It features modern, digital-first architecture to create smart workflow efficiency. With seamless connectivity, the platform adds value in neurooncology and breast cancer therapy. The platform features cutting-edge maneuverability, providing […]

Filed Under: 510(k), Big Data, Food & Drug Administration (FDA), Health Technology, Imaging, Neurological, Oncology, Radiosurgery/Radiation therapy, Regulatory/Compliance, Robotic-Assisted, Software / IT, Surgical, Surgical Robotics Tagged With: Carl Zeiss Meditec, FDA, Zeiss Medical Technology

Johnson & Johnson has positive dual-energy ablation data

April 2, 2025 By Sean Whooley

Johnson & Johnson MedTech announced 12-month data from its SmartfIRE clinical trial of the ThermoCool SmartTouch SF catheter. The medtech giant said investigators presented findings at the annual meeting of the European Heart Rhythm Association (EHRA) in Vienna, Austria. Outcomes showed that the dual-energy catheter proved 86.9% effective when treating patients with high adherence to […]

Filed Under: Cardiovascular, Catheters, Clinical Trials, Pulsed-Field Ablation (PFA), Radiosurgery/Radiation therapy, Vascular Tagged With: Biosense Webster, Johnson & Johnson, Johnson & Johnson MedTech

NeuroOne accelerates FDA submission timeline for nerve ablation tech

March 11, 2025 By Sean Whooley

NeuroOne (Nasdaq:NMTC) announced today that it accelerated the anticipated timeline of the FDA submission for its nerve ablation tech. Eden Prairie, Minnesota–based NeuroOne now expects to submit the trigeminal nerve ablation for FDA 510(k) clearance in May. It previously projected a submission by the end of June. Trigeminal nerve ablation, a minimally invasive procedure, uses […]

Filed Under: 510(k), Food & Drug Administration (FDA), Neurological, Radiosurgery/Radiation therapy, Regulatory/Compliance Tagged With: neuroone

Pulnovo Medical raises $100M for artery denervation tech

March 3, 2025 By Sean Whooley

Pulnovo Medical announced that it closed a Series C funding round worth proceeds of nearly $100 million. Qiming Venture Partners and existing shareholder Lilly Asia Ventures co-led the financing. Existing investors OrbiMed and Gaorong Capital participated on a super pro-rata basis as well. Shanghai-based Pulnovo said the $100 million represents made the round oversubscribed by […]

Filed Under: Business/Financial News, Cardiovascular, Funding Roundup, Radiosurgery/Radiation therapy, Vascular Tagged With: Pulnovo Medical

Biotronik, Egg Medical collaborate to protect healthcare workers from radiation

February 19, 2025 By Danielle Kirsh

Biotronik and Egg Medical are partnering to improve radiation protection for interventional healthcare workers. The two companies are collaborating to sell Egg Medical’s EggNest Radiation Protection Systems for healthcare workers in the U.S. The EggNest Systems, which includes EggNest XR, EggNest Protect, and EggNest Complete, can be used in a variety of fluoroscopy procedures without […]

Filed Under: Business/Financial News, Imaging, Radiosurgery/Radiation therapy Tagged With: Biotronik, Egg Medical

GT Medical raises $37M to advance bioresorbable radiation tile

January 16, 2025 By Sean Whooley

GT Medical Technologies announced today that it completed a $37 million first close of a Series D financing round. The funds support the completion of clinical studies for the Tempe, Arizona-based company’s GammaTile system. That includes the ROADS clinical study evaluating GammaTile for newly diagnosed brain metastases and the GESTALT clinical trial for patients with […]

Filed Under: Business/Financial News, Funding Roundup, Implants, Neurological, Oncology, Radiosurgery/Radiation therapy Tagged With: GT Medical, GT Medical Technologies

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 28
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy